2 TWENTYFOURSEVENBIOPHARMA Issue 2 / June 2025 GLATT PHARMACEUTICAL SERVICES 44 Non-negotiable imperatives for pharma production ALFASIGMA 46 Meeting Morpho, Alfasigma’s CDMO AGC PHARMA CHEMICALS 48 The critical role of a resilient and flexible supply chain SHILPA PHARMA LIFESCIENCES 50 Shilpa launches hybrid CDMO at DCAT THERMO FISHER 52 Thermo Fisher’s Accelerator™ Drug Development and the future of biopharma innovation AVENACY 54 Innovating in specialty pharma: Jeffrey Yordon on Avenacy’s strategy for market differentiation and growth CONTENTS 1 WELCOME NEWS 4 BIO INTERNATIONAL CONVENTION 22 BIO 2025: The roundtable BIOTECH 28 Powering the pipeline: The technologies and deals rewriting biotech’s playbook REGULATION 32 Reform or regulatory overreach? The mixed legacy of Trump’s FDA reforms WOMEN IN SCIENCE 36 JAYASHREE AIYA Chief Scientific Officer Syngene ARTIFICIAL INTELLIGENCE 40 From data to discovery: How AI is transforming the drug pipeline
RkJQdWJsaXNoZXIy MjY2OTA4MA==